Company: MYSZ
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001641172-25-010830
Chunk: 6

Company: My Size, Inc.
Filing Date: 2025-05-15
Form: 10-Q
Item: Part I, Item 1
Chunk 6
---
 unless the context indicates otherwise.

Subsequent to the date of these financial statements,
the Company established an additional subsidiary, New Percentil, S.L., a limited liability company incorporated under the laws of Spain.
See note 9b.

My Size, Inc., was incorporated and commenced
operations in September 1999, as Topspin Medical Inc. (“Topspin”), a private company registered in the State of Delaware.
In December 2013, the Company changed its name to Knowledgetree Ventures Inc. Subsequently, in February 2014, the Company changed its
name to My Size, Inc. Topspin was engaged, through its Israeli subsidiary, in research and development in the field of cardiology and
urology.

On July 25, 2016, the Company’s common stock
began publicly trading on the Nasdaq Capital Market under the symbol “MYSZ”.  

From September 1, 2005 to March 27, 2024, the Company’s common
stock was traded on the Tel Aviv Stock Exchange.

    b.
    
    Since inception, the Company has incurred significant losses and negative
    cash flows from operations and has an accumulated deficit of $64,936. The Company has financed its operations mainly through fundraising
    from various investors.
     
    The Company’s management expects that the Company will continue to
    generate losses and negative cash flows from operations for the foreseeable future. Based on the projected cash flows and cash balances
    as of the date of these financial statements, management is of the opinion that there is an uncertainty that its existing cash will be
    sufficient to fund operations for a period of more than 12 months. As a result, there is substantial doubt about the Company’s ability
    to continue as a going concern.
     
    Management’s plans include the continued
commercialization of the Company’s products and acquisition of technology, intellectual property or businesses and securing sufficient
financing through the sale of additional equity securities, debt or capital inflows from strategic partnerships. Management is actively
looking for additional technology and commercial opportunities that will increase the company’s cashflow. The company has sold additional
securities for $1,995 see note 9a. Additional funds may not be available when the Company needs them, on terms that are acceptable to
it, or at all. If the Company is unsuccessful in commercializing its products and securing sufficient financing, it may need to cease
operations.  

    The financial statements include no adjustments